Literature DB >> 27345337

Superselective Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma: Rationale, Technique, and Outcome.

Shiro Miyayama1, Osamu Matsui2.   

Abstract

Conventional transarterial chemoembolization with ethiodized oil and gelatin sponge (GS) particles is a standard technique for hepatocellular carcinoma. Ethiodized oil can temporarily block tumor sinusoids, portal venules, hepatic sinusoids, and arterial microcommunications. By adding GS embolization, strong ischemic effects not only on the tumor but also on the surrounding liver parenchyma can be achieved. Superselective conventional transarterial chemoembolization is mainly indicated for patients with Child-Pugh scores of 5-8, tumors ≤ 7 cm, and ≤ 5 lesions. According to a Japanese nationwide survey, the 5-year survival rate of patients with Child-Pugh class A and a single tumor was 52%.
Copyright © 2016 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27345337     DOI: 10.1016/j.jvir.2016.04.014

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  17 in total

1.  Metformin attenuates hypoxia-induced resistance to cisplatin in the HepG2 cell line.

Authors:  Hiromasa Fujita; Katsumi Hirose; Mariko Sato; Ichitaro Fujioka; Tamaki Fujita; Masahiko Aoki; Yoshihiro Takai
Journal:  Oncol Lett       Date:  2018-12-24       Impact factor: 2.967

2.  Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma.

Authors:  Jin Woo Choi; Jin Wook Chung; Dong Ho Lee; Hyo-Cheol Kim; Saebeom Hur; Myungsu Lee; Hwan Jun Jae
Journal:  Eur Radiol       Date:  2017-12-07       Impact factor: 5.315

Review 3.  Current locoregional therapies and treatment strategies in hepatocellular carcinoma.

Authors:  L Cardarelli-Leite; A Hadjivassiliou; D Klass; J Chung; S G F Ho; H J Lim; P T W Kim; A Mujoomdar; D M Liu
Journal:  Curr Oncol       Date:  2020-11-01       Impact factor: 3.677

Review 4.  Clinical practice of transarterial chemoembolization for hepatocellular carcinoma: consensus statement from an international expert panel of International Society of Multidisciplinary Interventional Oncology (ISMIO).

Authors:  Jian Lu; Ming Zhao; Yasuaki Arai; Bin-Yan Zhong; Hai-Dong Zhu; Xiao-Long Qi; Thierry de Baere; Uei Pua; Hyun Ki Yoon; David C Madoff; Gao-Jun Teng
Journal:  Hepatobiliary Surg Nutr       Date:  2021-10       Impact factor: 7.293

5.  Feasibility and Techniques of Securing 3D-Safety Margin in Superselective Transarterial Chemoembolization to Improve Local Tumor Control for Small Hepatocellular Carcinoma: An Intend-to-Treat Analysis.

Authors:  Ching Charoenvisal; Toshihiro Tanaka; Hideyuki Nishiofuku; Hiroshi Anai; Takeshi Sato; Takeshi Matsumoto; Nagaaki Marugami; Kimihiko Kichikawa
Journal:  Liver Cancer       Date:  2021-01-12       Impact factor: 11.740

6.  Retrospective European Multicentric Evaluation of Selective Transarterial Chemoembolisation with and without Balloon-Occlusion in Patients with Hepatocellular Carcinoma: A Propensity Score Matched Analysis.

Authors:  Rita Golfieri; Mario Bezzi; Gontran Verset; Fabio Fucilli; Cristina Mosconi; Alberta Cappelli; Alexandro Paccapelo; Pierleone Lucatelli; Nicolas Magand; Agnes Rode; Thierry De Baere
Journal:  Cardiovasc Intervent Radiol       Date:  2021-03-11       Impact factor: 2.740

7.  Efficacy of Superselective Conventional Transarterial Chemoembolization Using Guidance Software for Hepatocellular Carcinoma within Three Lesions Smaller Than 3 cm.

Authors:  Shiro Miyayama; Masashi Yamashiro; Rie Ikeda; Junichi Matsumoto; Kiyotaka Takeuchi; Naoko Sakuragawa; Teruyuki Ueda; Taku Sanada; Kazuo Notsumata; Takuro Terada
Journal:  Cancers (Basel)       Date:  2021-12-19       Impact factor: 6.639

8.  Comprehensive Analysis of Factors Affecting Clinical Response and Short-Term Survival to Drug-Eluting Bead Transarterial Chemoembolization for Treatment in Patients With Liver Cancer.

Authors:  Xia Wu; Ran Chen; Weiliang Zheng; Hongjie Hu
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

9.  Appraisal of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage B.

Authors:  Jeong-Ju Yoo; Su Jong Yu; Bora Lee; Eun Ju Cho; Jeong-Hoon Lee; Sang Gyune Kim; Yoon Jun Kim; Young Seok Kim; Jung-Hwan Yoon
Journal:  Gut Liver       Date:  2020-05-15       Impact factor: 4.519

10.  Predictive model for acute abdominal pain after transarterial chemoembolization for liver cancer.

Authors:  Li-Fang Bian; Xue-Hong Zhao; Bei-Lei Gao; Sheng Zhang; Guo-Mei Ge; Dong-Di Zhan; Ting-Ting Ye; Yan Zheng
Journal:  World J Gastroenterol       Date:  2020-08-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.